Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Researchers made two new compounds that could be used for medicine.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Asiasari radix extract may relieve certain types of pain by affecting GABA and NMDA receptors.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Certain alkaloids could help create new coronavirus drugs.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.